COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #83
Source   PDF   Share   Tweet
See all 143 studies
7/17
Inconc.
Late treatment study
Lyngbakken et al., Research Square, doi:10.21203/rs.3.rs-44055/v1 (Preprint)
Small RCT of nasopharyngeal viral load not showing significant differences. The rate of reduction for HC Q was 0.24 [0.03-0.46] RNA copies/mL/24h, and 0.14 [-0.10-0.37] for the control group (71% faster with HC Q but not statistically significant with the small sample size of 27 HC Q and 26 control patients). Analysis only over 96 hours.
NCT04316377
time to viral-, ↓71.0%, p=0.51, improvement in viral load reduction rate
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit